Synthetic DMARDs May Blunt Pneumococcal Vaccine Response in Systemic Sclerosis Synthetic DMARDs May Blunt Pneumococcal Vaccine Response in Systemic Sclerosis
Pneumococcal vaccination yields a satisfactory antibody response in patients with systemic sclerosis (SSc), but synthetic disease-modifying antirheumatic drugs (DMARDs) might reduce the vaccine response in these individuals, according to a report from Sweden.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Source Type: news
More News: Health | Meningitis Vaccine | Pneomococcal Vaccine | Rheumatology | Scleroderma | Sweden Health | Vaccines